News Focus
News Focus
icon url

frobinso

03/14/22 4:22 PM

#95594 RE: beurstips #95591

If our PDK is accepted by a foundry or if a foundry's PDK contains the use of Perkinamine, that does it for me from a goal perspective, and I believe him when he says he is working with multiple foundries.

I do not recall the "achieving mass commercialization" as being the specifically stated goal, but I personally believe he is on track, and securing an amazing intellectual property position while he is at it-methodically.

If you sit back and watch him playing and winning the long game, you would feel less anxious about which week or month news drops. News will drop soon enough, I believe.

If Intel's recent acquisition was with a foundry that we are working with under NDA, I also believe that is an exciting development for a company that is on a turn-around mission to reclaim leadership status and likely has a government backed pocket-book where acquisition price give or take X-billion here or there is not of great concern.

icon url

theroc66

03/14/22 6:40 PM

#95622 RE: beurstips #95591

Then Beurstip,
I urge you to re-read or re-listen:
The only commitment Dr Lebby made is for a commercial agreement by May 2022.
You should definitely read before you attribute false claims in writing.
You might find yourself slendering...
GLTAL
AR.